ghk-cu injection sites subcutaneous Dosing: 1.7mg/Day Injectable (2026) 7.4 Subcutaneous Injections – Clinical

Since both drugs influence gastrointestinal function, starting with lower doses and gradual titration is generally advised

Acknowledgements We would like to thank Editage (www.editage.com) for English language editing

After iv administration, the entire dose of the drug is immediately available for metabolism and excretion

Stimulation of natural killer and antibody-dependent cellular cytotoxicity activities in mouse leukocytes by bombesin, gastrin-releasing peptide and neuromedin C: involvement of cyclic AMP, inositol 1,4,5-trisphosphate and protein kinase C

The product ships as a lyophilised blue powder with a Certificate of Analysis (COA), HPLC purity 99 %

Karimi, Mozhgan